Fredrik H Nystrom
Linköping, 58185, Sweden
NCT Number: NCT02227511
Recruitment of 28 subjects that will be randomized to consume fruit or nuts as snacks between regular meals for two months. Laboratory tests for cardiovascular risk factors, metabolic rate, liver steatosis and physical activity are investigated ahead of start of the study and at the end of the trial period och two months. Participants will be allowed to buy fruits or nuts on their own but to keep track (diaries) of the amount consumed. They will be reimbursed for the costs of the snacks.
Looking for future studies?
Notify Me18 year–76 year
All sexes
Interventional
Not applicable
Linköping, 58185, Sweden
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Randomization to extra fruit or nuts as snacks
Other names: Randomization to extra fruit or nuts as snacks
Time frame: two months
exact measurement of fat in the liver by liver spectroscopy
Time frame: two months
Collection of markers for cardiovascular risk including glucose, insulin, lipoproteins etc. Analyses will be performed from blood samples.
University Hospital, Linkoeping
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00757367
Glucose Metabolism Disorders, Healthy Subjects
Phoenix, Arizona, United States
View Trial DetailsNCT02150889
Body Weight, Diabetes Mellitus
Minneapolis, Minnesota, United States
View Trial DetailsNCT06315725
Autoimmune Diseases, Diabetes Mellitus
Montreal, Quebec, Canada
View Trial DetailsNCT07470125
Healthy Subjects
Seoul, South Korea
View Trial Details